Alfredo Puing

🇪🇨Ecuadorian | ID doc @YaleMed

[Journal of Infectious Diseases @JIDJournal]

Happy Sunday everyone! We're the official account for The Journal of Infectious Diseases – an official journal of @IDSAInfo. Follow us for updates and to comment on the latest articles from JID, the premier global journal for original research on infectious diseases.

[Clinical Infectious Diseases @CIDJournal]

Hi everyone! 👋 We're the official account for Clinical Infectious Diseases. An official journal of @IDSAinfo, CID is one of the world's leading journals on ID. Follow us to stay up to date and comment on high-quality articles on clinical ID, public health, microbiology & more.

[Open Forum Infectious Diseases @OFIDJournal]

Hello there! We're the official account for Open Forum Infectious Diseases – an official journal of @IDSAInfo. OFID publishes clinical, translational and basic research in a fully open access, online journal. Follow us to stay up to date and comment on all our latest content.

[Alfredo Puing @alfredopuing]

@sebpoule Disseminated gonococcal infection?

[Alfredo Puing @alfredopuing]

@RicardoLaHozMD @jfsisaacs5 @matthew_mei @AaronGoodman33 @nihardesai7 @ftorriani @DeepaDNanayakk1 Maribavir is a/w less AKI and cytopenia than FOS and VGCV/GCV, respectively. However, it is only FDA approved for R/R CMV. It can only be given PO so if there is no issues with oral intake (conditioning-related GI toxicity or acute GI GVHD) it may be an off-label option

[Alfredo Puing @alfredopuing]

@DrNeilStone This is an amazing tweetorial from the dearly missed @FranciscoMarty_ https://t.co/EKf1BzjKYy

[Francisco Marty, MD @FranciscoMarty_]

Finally got to analyze & put my thoughts together on the recent #posaconazole vs. #voriconazole phase 3 trial for invasive #aspergillosis published in .@TheLancet a few weeks ago.
Best is to put the major trials of the 3 #VIP triazoles done over the last 20 years in perspective!

[TransplantID Journal @TheTxIDjournal]

New job opportunity @cityofhope - Assistant Clinical Professor in Infectious Diseases w/ a focus on HCT and cancer pts. Great team of experts that you would be joining.

Plus ☀️ California...

See here for more information

https://t.co/s54tXh81hy

[Alfredo Puing @alfredopuing]

Happy to share our research letter on TMP-SMX avoidance and nocardiosis - 💊TMP-SMX allergy evaluation/rechallenge on pts receiving 2nd line PJP ppx may allow its tolerance and could prevent other OIs - Great work @AnneLiuMD @ArunaSubraman12 !! https://t.co/9XCicqhPxC

[U.S. FDA @US_FDA]

Today, FDA amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals. https://t.co/MYoTvX82lM

[Alfredo Puing @alfredopuing]

@RazonableMD Thank you @RazonableMD. Happy to share our experience @cityofhope showing that mAb therapy against COVID-19 is safe and effective in cancer patients who are at high risk for disease progression and mortality.

[Alfredo Puing @alfredopuing]

FDA authorizes REGEN-COV (casirivimab-imdevimab) for post-exposure prophylaxis in adults and pediatric individuals who are at high risk for progression to severe COVID-19, including hospitalization or death. https://t.co/X6YTd9Wmbq

[Richard Carapaz M @RichardCarapazM]

Una poesía con versos aclamados por un pequeño pueblo. Este oro es para quien realmente ha creído en mí. También para mis hijos, esposa y mis padres. Los amo! Sepan seguro que los días más grandes se escriben con la misma tinta de olimpo. Gracias Ecuador 🇪🇨

[Eric Topol @EricTopol]

In California, the Delta variant is 30% of cases, and vaccinations are fairly high (>61% population 1-dose or more), cases have started to creep up again, 17% in past 2 weeks and that's with 62% less testing (<-complacency)

[ID Journal Club @IDJClub]

Next #IDJClub: May 3 (9pm EDT)

In honor of our late colleague and friend Francisco Marty, a giant in the field of infections of immunocompromised hosts, we’ll discuss posaconazole vs voriconazole as primary therapy for invasive #aspergillosis

https://t.co/g3YFmwcXKF

[Alfredo Puing @alfredopuing]

@NicoBarrosID @AST_IDCOP @NicoBarrosID for ID COP early career member-at-large!!! Vote! @AST_IDCOP @AST_info @RicardoLaHozMD

[Nicolas Barros @NicoBarrosID]

Dont forget to cast your vote in the 2021 COP election @AST_IDCOP I'm running for early career member-at-large and would love your support! #TxID #vote

[Nicolas Barros @NicoBarrosID]

Ivermectin had no role in management of mild COVID-19.
@alfredopuing @MarianaLanata @camillewebb @MauricioLaRosa1

Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 https://t.co/t9ZO86Q5VB via @JAMA_current part of @JAMANetwork

[Justine Abella Ross @abella_ross]

If someone tests positive for COVID but is admitted for reasons other than COVID but has risk factors for progressing to severe disease. What treatment would you give? @AnnieC_ID_MD @Darcy_ID_doc @BalcombeShannon @OncIDPharmd @ErinMcCreary @IDRoadrunner @DHpharmd

[Alfredo Puing @alfredopuing]

🏆 B.S.C.